Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-4,611
Closed -$204K – 270
2019
Q1
$204K Sell
4,611
-60
-1% -$2.57K 0.03% 237
2018
Q4
$203K Sell
4,671
-1,195
-20% -$52.7K 0.03% 224
2018
Q3
$262K Sell
5,866
-66
-1% -$2.82K 0.04% 218
2018
Q2
$237K Buy
5,932
+765
+15% +$30.1K 0.03% 221
2018
Q1
$207K Hold
5,167
– – 0.03% 244
2017
Q4
$222K Sell
5,167
-685
-12% -$31.6K 0.03% 238
2017
Q3
$291K Sell
5,852
-16
-0.3% -$774 0.04% 203
2017
Q2
$281K Sell
5,868
-247
-4% -$11.8K 0.04% 206
2017
Q1
$277K Sell
6,115
-726
-11% -$30.8K 0.04% 212
2016
Q4
$277K Sell
6,841
-94
-1% -$3.7K 0.04% 202
2016
Q3
$265K Sell
6,935
-1,649
-19% -$66.2K 0.04% 210
2016
Q2
$359K Buy
8,584
+2,617
+44% +$107K 0.06% 170
2016
Q1
$240K Buy
+5,967
New +$240K 0.04% 196
2015
Q4
– Sell
-8,944
Closed -$425K – 258
2015
Q3
$425K Buy
8,944
+614
+7% +$31.3K 0.08% 160
2015
Q2
$413K Buy
+8,330
New +$422K 0.07% 179

Other funds holding SNY

CIBC Bank USA's SNY Position: Q2 2019 in Review

CIBC Bank USA sold out of Sanofi (SNY) in Q2 2019, closing a stake of 4,611 shares — an estimated $204K sold.

CIBC Bank USA first reported a position in SNY in Q2 2015 and held it in 15 quarters. The position peaked at $425K in Q3 2015. 482 funds tracked by Wall St. Rank hold SNY as of Q2 2019.

  • CIBC Bank USA reported no remaining Sanofi position as of Q2 2019 after selling out during the quarter.
  • CIBC Bank USA sold 4,611 Sanofi shares in Q2 2019, an estimated $204K.
  • CIBC Bank USA first reported a position in Sanofi in Q2 2015 and held it in 15 quarters.
  • CIBC Bank USA's Sanofi position peaked at $425K in Q3 2015.
  • 482 funds tracked by Wall St. Rank held Sanofi as of Q2 2019.

Based on CIBC Bank USA's 13F filing for Q2 2019, filed 31 Jul 2019.